|
|
|
|
|
|
|
10.11.26 - 12:01
|
MaxCyte to Acquire Akron Bio, Expanding its Offerings Across Cell Therapy Manufacturing and Expecting to Nearly Double Revenue Base (GlobeNewswire EN)
|
|
|
ROCKVILLE, Md., Nov. 10, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (NASDAQ: MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it has entered into a definitive agreement to acquire Akron BioProducts LLC (“Akron” or “Akron Bio”) from affiliates of Arcline Investment Management (“Arcline”) for total consideration of $151.8 million. The transaction is expected to close before the end of 2026, subject to customary closing conditions....
|
|
|
28.10.26 - 13:09
|
MaxCyte to Participate in Three Upcoming Investor Conferences (GlobeNewswire EN)
|
|
|
ROCKVILLE, Md., Oct. 28, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (NASDAQ: MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell therapeutics, today announced Company management will participate in three upcoming investor conferences....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.07.26 - 22:09
|
MaxCyte to Report Second Quarter 2026 Financial Results on August 12, 2026 (GlobeNewswire EN)
|
|
|
ROCKVILLE, Md., July 15, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the second quarter 2026 after the U.S. market close on Wednesday, August 12th, 2026. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time....
|
|
|
09.07.26 - 15:39
|
Maryland Tech Council Announces New Board of Directors (Business Wire)
|
|
|
ROCKVILLE, Md.--(BUSINESS WIRE)--The Maryland Tech Council (MTC), the largest technology and life sciences trade association in the state, today announced the election of new members to its Board of Directors. Bringing decades of expertise across technology, life sciences, and related industries, the directors will help guide MTC's strategy and planning for the 2-year term.
"We are excited to collaborate with this dynamic group of new board members," said Kelly Schulz, CEO of the Maryland Tech Council. "MTC's priorities are clear: protect and expand Maryland's innovation ecosystem, and deliver tangible, impactful value to our members. Each board member will play a vital role in helping us achieve these objectives."
The directors are:
Fouad Atouf, Ph.D, USP Convention
Jay Gelfman, MaxCyte, Inc.
Liz Pujolas, Amgen USA
Daniel Mendelsohn, Venable
Megan Norris, growth[period]
Jared Smith, MBA, CEcD, Montgomery County Economic Development Corporation
About the Maryland Tech Council
The Maryland Tech Council ...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
